Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genetic Technologies Ltd (NASDAQ:GENE)

1.21
Delayed Data
As of Dec 09
 +0.02 / +1.68%
Today’s Change
1.12
Today|||52-Week Range
3.25
-54.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues3.5M4.2M1.7M600.0K
 
 
 
 
 
Cost of Goods Sold4.2M1.6M695.8K496.9K
 
 
 
 
 
Depreciation And Amortization407.1K310.7K193.4K283.9K
 
 
 
 
 
 
Operating ExpensesGross Income-1.2M2.3M786.5K-180.7K
 
 
 
 
 
General Expenses13.2M12.5M9.9M6.5M
 
 
 
 
 
Research And Development3.4M2.9M2.3M287.8K
 
 
 
 
 
Total Operating Expenses17.9M14.4M10.7M7.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.4M-10.2M-9.1M-6.7M
 
 
 
 
 
Extraordinary Charge---323.9K-371.7K--
 
 
 
Interest Expense On Debt39.8K683.2K220.5K0.00
 
 
 
 
Equity In Earnings-446.9K-332.9K0.000.00
 
 
 
Other Expenses4.9M1.8M2.2M245.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.3M-9.3M-7.4M-6.4M
 
 
 
 
 
Income Taxes-185.0K-329.0K-92.6K-261.8K
 
 
 
 
 
Minority Interest-52.2K-8.5K0.000.00
 
 
 
Net Income-9.5M-9.3M-7.3M-6.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.1M3.8M7.2M11.4M
 
 
 
 
 
Shares To Calculate EPS Diluted3.1M3.8M7.2M11.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.02-$2.42-$1.02-$0.53
 
 
 
 
 
EPS Diluted-$3.02-$2.42-$1.02-$0.53